These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 21696294)
1. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294 [TBL] [Abstract][Full Text] [Related]
2. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Budhian A; Siegel SJ; Winey KI Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944 [TBL] [Abstract][Full Text] [Related]
3. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954 [TBL] [Abstract][Full Text] [Related]
4. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
5. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug. D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
8. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
9. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity. Liu J; Qiu Z; Wang S; Zhou L; Zhang S Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138 [TBL] [Abstract][Full Text] [Related]
10. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X; Zou W; Liu C; Zhang N; Fu C Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [TBL] [Abstract][Full Text] [Related]
11. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Saxena V; Sadoqi M; Shao J Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634 [TBL] [Abstract][Full Text] [Related]
12. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method. Choi SH; Park TG Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477 [TBL] [Abstract][Full Text] [Related]
13. Cellular uptake of Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method. Xiong S; Zhao X; Heng BC; Ng KW; Loo JS Biotechnol J; 2011 May; 6(5):501-8. PubMed ID: 21259442 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
15. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
16. PLGA-based drug delivery systems: importance of the type of drug and device geometry. Klose D; Siepmann F; Elkharraz K; Siepmann J Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
18. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation. Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661 [TBL] [Abstract][Full Text] [Related]
19. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
20. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]